{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:16:52Z","timestamp":1778041012657,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["GACR 24-10712S"],"award-info":[{"award-number":["GACR 24-10712S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["RVO67985823"],"award-info":[{"award-number":["RVO67985823"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neuropharm.2026.110975","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:11:52Z","timestamp":1776237112000},"page":"110975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Endogenous TRPV1 agonist OLDA prevents mu-opioid receptor desensitization and preserves analgesia in sensitized nociceptive circuits"],"prefix":"10.1016","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-1412","authenticated-orcid":false,"given":"Mario","family":"Heles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5655-4676","authenticated-orcid":false,"given":"Daniel","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-8542","authenticated-orcid":false,"given":"Jiri","family":"Palecek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110975_bib1","series-title":"Frontiers in Physiology","article-title":"The interaction of TRPV1 and lipids: insights into lipid metabolism","author":"Abdalla","year":"2022"},{"key":"10.1016\/j.neuropharm.2026.110975_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.11.027","article-title":"Mechanical allodynia and enhanced responses to capsaicin are mediated by PI3K in a paclitaxel model of peripheral neuropathy","volume":"146","author":"Adamek","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110975_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aav0711","article-title":"TRPV1 promotes opioid analgesia during inflammation","volume":"12","author":"Basso","year":"2019","journal-title":"Sci. Signal."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110975_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103421","article-title":"TRPV1: structure, endogenous agonists, and mechanisms","volume":"21","author":"Ben\u00edtez-Angeles","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110975_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejpain.2009.08.005","article-title":"Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold thresholds in the rat","volume":"14","author":"B\u00f6lcskei","year":"2010","journal-title":"Eur. J. Pain"},{"issue":"389","key":"10.1016\/j.neuropharm.2026.110975_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","author":"Caterina","year":"1997","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.neuropharm.2026.110975_bib7","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1523\/JNEUROSCI.4170-07.2008","article-title":"Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway","volume":"28","author":"Chen","year":"2008","journal-title":"J. Neurosci."},{"issue":"16","key":"10.1016\/j.neuropharm.2026.110975_bib8","doi-asserted-by":"crossref","first-page":"13633","DOI":"10.1074\/jbc.M211231200","article-title":"N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia","volume":"278","author":"Chu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110975_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nm.4262","article-title":"Loss of \u03bc opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia","volume":"23","author":"Corder","year":"2017","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110975_bib10","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1476-5381.2012.02080.x","article-title":"Deciphering \u03bc-opioid receptor phosphorylation and dephosphorylation in HEK293 cells","volume":"167","author":"Doll","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.neuropharm.2026.110975_bib11","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2026.110975_bib12","article-title":"The mysteries of capsaicin-sensitive afferents","volume":"vol. 11","author":"Fischer","year":"2020"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110975_bib13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.biopsych.2014.01.021","article-title":"Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5","volume":"76","author":"Gl\u00fcck","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110975_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02335-4","article-title":"Chemokine CCL2 prevents opioid-induced inhibition of nociceptive synaptic transmission in spinal cord dorsal horn","volume":"18","author":"Heles","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110975_bib15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/bjp.2008.375","article-title":"Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief","volume":"155","author":"Jancs\u00f3","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110975_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02485-z","article-title":"N -Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomes","volume":"19","author":"Joffre","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110975_bib17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neuropharm.2005.05.003","article-title":"Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats","volume":"49","author":"Kanai","year":"2005","journal-title":"Neuropharmacology"},{"issue":"16","key":"10.1016\/j.neuropharm.2026.110975_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000017118","article-title":"Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects","volume":"118","author":"Kandasamy","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2026.110975_bib19","series-title":"Pharmacology Research and Perspectives","article-title":"Addressing opioid tolerance and opioid-induced hypersensitivity: recent developments and future therapeutic strategies","author":"Khan","year":"2021"},{"key":"10.1016\/j.neuropharm.2026.110975_bib20","series-title":"Behavioural Pharmacology","article-title":"Peripherally acting opioid analgesics and peripherally-induced analgesia","author":"Mart\u00ednez","year":"2020"},{"key":"10.1016\/j.neuropharm.2026.110975_bib21","series-title":"JOURNALOF NEUROPHYSIOLOGY","article-title":"Responses of spinothalamic tract cells to mechanical and thermal stimulation of skin in rats with experimental peripheral neuropathy","author":"Palecek","year":"1992"},{"key":"10.1016\/j.neuropharm.2026.110975_bib22","series-title":"Nature Reviews Molecular Cell Biology","article-title":"Seven-transmembrane receptors","author":"Pierce","year":"2002"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110975_bib23","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in \u03b2-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110975_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093688","article-title":"Activation of mu opioid receptors sensitizes Transient Receptor Potential Vanilloid Type 1 (TRPV1) via \u03b2-arrestin-2-mediated cross-talk","volume":"9","author":"Rowan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.110975_bib25","series-title":"Proceedings of the National Academy of Sciences of the United States of America","article-title":"TRPV1 is a physiological regulator of \u03bc-opioid receptors","author":"Scherer","year":"2017"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110975_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.celrep.2013.07.002","article-title":"Opiates modulate thermosensation by internalizing cold receptor TRPM8","volume":"4","author":"Shapovalov","year":"2013","journal-title":"Cell Rep."},{"issue":"39","key":"10.1016\/j.neuropharm.2026.110975_bib27","doi-asserted-by":"crossref","first-page":"30115","DOI":"10.1074\/jbc.M110.141549","article-title":"Arresting a transient receptor potential (TRP) channel: \u03b2-arrestin 1 mediates ubiquitination and functional down-regulation of TRPV4","volume":"285","author":"Shukla","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110975_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-8-177","article-title":"Modulation of spinal cord synaptic activity by tumor necrosis factor \u03b1 in a model of peripheral neuropathy","volume":"8","author":"Spicarova","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110975_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1152\/jn.00024.2009","article-title":"The role of the TRPV1 endogenous agonist N-oleoyldopamine in modulation of nociceptive signaling at the spinal cord level","volume":"102","author":"Spicarova","year":"2009","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2026.110975_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-7-49","article-title":"Tumor necrosis factor \u03b1 sensitizes spinal cord TRPV1 receptors to the endogenous agonist N-oleoyldopamine","volume":"7","author":"Spicarova","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.110975_bib31","article-title":"Peppers and poppies: a perspective on nociceptors and pain control","author":"Staedtler","year":"2025","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110975_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0031-6997(24)01403-0","article-title":"Vanilloid (Capsaicin) receptors and mechanisms","volume":"51","author":"Szallasi","year":"1999","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110975_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2003.12.025","article-title":"Direct evidence for activation and desensitization of the capsaicin receptor by N-oleoyldopamine on TRPV1-transfected cell, line in gene deleted mice and in the rat","volume":"361","author":"Szolcs\u00e1nyi","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110975_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073712","article-title":"Hypersensitivity induced by intrathecal bradykinin administration is enhanced by n-oleoyldopamine (Olda) and prevented by trpv1 antagonist","volume":"22","author":"Uchytilova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"28","key":"10.1016\/j.neuropharm.2026.110975_bib35","doi-asserted-by":"crossref","first-page":"19540","DOI":"10.1074\/jbc.M707865200","article-title":"Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization","volume":"283","author":"Vetter","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.110975_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19042387","article-title":"Side effects of opioids are ameliorated by regulating TRPV1 receptors","author":"Wang","year":"2022"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110975_bib37","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/vms3.318","article-title":"Baicalin prevents the up-regulation of TRPV1 in dorsal root ganglion and attenuates chronic neuropathic pain","volume":"6","author":"Wang","year":"2020","journal-title":"Veterinary Medicine and Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110975_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085259","article-title":"Metabolism of N-acylated-dopamine","volume":"9","author":"Zajac","year":"2014","journal-title":"PLoS One"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:07:09Z","timestamp":1778040429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"alternative-id":["S0028390826001486"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110975","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous TRPV1 agonist OLDA prevents mu-opioid receptor desensitization and preserves analgesia in sensitized nociceptive circuits","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110975"}}